文献速递外周动脉疾病

BASIL试验:股腘动脉旁路术与球囊血管成形术±裸金属支架的临床结局比较

A Comparison of Clinical Outcomes Following Femoropopliteal Bypass or Plain Balloon Angioplasty with Selective Bare Metal Stenting in the Bypass Versus Angioplasty in Severe Ischaemia of the Limb (BASIL) Trial.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2019-02-18

基于BASIL-1试验数据,比较因股腘动脉病变(伴或不伴膝下病变)所致慢性肢体威胁性缺血患者接受开放手术旁路(OSB,n=128)或普通球囊血管成形术(PBA,n=183,其中6例置入裸金属支架)的结局。OSB即刻技术成功率更高(98% vs. 81%,p<.001),且免于主要肢体不良事件(HR 1.51,p=.04)和免于再干预(HR 1.68,p=.02)更优,但无截肢生存、总生存和保肢无差异。

要点

  • OSB即刻技术成功率显著高于PBA±BMS(98% vs. 81%,p<.001)。
  • OSB的免于主要肢体不良事件和免于再干预显著优于PBA±BMS。
  • 两组无截肢生存、总生存和保肢率无显著差异。

核心结论

  • OSB与PBA±BMS在无截肢生存、总生存和保肢方面相似,但OSB的主要肢体不良事件和再干预显著更少。
  • PBA±BMS短期可能资源消耗更少,但长期优势不明显。
  • 数据支持对股腘动脉病变所致CLTI患者尽可能首选OSB作为血运重建术式。

研究设计与样本

  • 基于BASIL-1试验病例记录表数据的比较分析。
  • 原发性OSB组n=128(静脉89例,合成39例),原发性PBA组n=183(6例置入BMS)。
  • OSB组平均随访46.2个月,PBA组平均随访43.6个月。

主要发现

  • OSB即刻技术成功率为98%,PBA±BMS为81%(p<.001)。
  • OSB组平均指数住院时间更长(p=.001),但12个月住院天数无差异。
  • OSB的FF-MALE更优(HR 1.51;p=.04),FF-R更优(HR 1.68;p=.02)。
  • AFS(HR 1.18;p=.4)、OS(HR 1.14;p=.5)和LS(HR 1.09;p=.8)两组无显著差异。

临床怎么用

  • 对于股腘动脉病变所致CLTI,若解剖条件允许,应优先考虑OSB作为初次血运重建术式。
  • PBA±BMS可作为短期资源消耗较少的替代选择,但需告知再干预风险较高。

局限性

  • PBA组中仅6例置入BMS,BMS的效应无法充分评估。
  • PBA±BMS组当前吸烟者比例显著更高,可能影响结局比较。
  • 为BASIL-1试验数据的回顾性比较分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare outcomes in patients with chronic limb threatening ischaemia (CLTI) due to femoropopliteal (FP), with or without infrapopliteal (IP), disease who underwent FP (vein or synthetic) open surgical bypass (OSB), or plain balloon angioplasty (PBA), with or without bare metal stenting (BMS), in the Bypass versus Angioplasty in Severe Ischaemia of the Limb (BASIL-1) trial. METHODS: Data were extracted from BASIL-1 case record forms. Outcomes reported include immediate technical success, freedom from major adverse limb events (FF-MALE) and further re-intervention (FF-R), amputation free survival (AFS), overall survival (OS), and limb salvage (LS). RESULTS: Patients underwent primary OSB (n = 128; 89 vein, 39 synthetic) or primary PBA (n = 183; six had BMS). Mean follow up was 46.2 and 43.6 months respectively. Patients were well matched at baseline except that PBA ± BMS patients were significantly more likely to be current smokers. There was no difference in overall or IP (runoff) Bollinger angiogram scores between groups. Immediate technical success was significantly higher for OSB (98% vs. 81%; p < .001). OSB was associated with a longer mean index hospital admission (p = .001), but there was no difference in hospital days at 12 months. FF-MALE (hazard ratio [HR] 1.51; p = .04) and FF-R (HR 1.68; p = .02) but not AFS (HR 1.18; p = .4), OS (HR 1.14; p = .5), and LS (HR 1.09; p = .8) were significantly better after OSB. CONCLUSION: Although AFS, OS, and LS were similar in the two groups, OSB was associated with significantly fewer MALE and re-interventions. So, while PBA ± BMS may be a less resource intensive (expensive) and morbid option in the short term, this appears unlikely to be the case in the longer term. Present data add further weight to the argument that, where possible, patients presenting with CLTI due to FP disease should be offered OSB as their primary revascularisation procedure.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Meecham L, Bate G, Patel S, et al. A Comparison of Clinical Outcomes Following Femoropopliteal Bypass or Plain Balloon Angioplasty with Selective Bare Metal Stenting in the Bypass Versus Angioplasty in Severe Ischaemia of the Limb (BASIL) Trial. Eur J Vasc Endovasc Surg. 2019. PMID: 30786974. doi:10.1016/j.ejvs.2019.01.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。